These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30900776)

  • 41. Baboon syndrome following oral roxithromycin.
    Amichai B; Grunwald MH
    Clin Exp Dermatol; 2002 Sep; 27(6):523. PubMed ID: 12372101
    [No Abstract]   [Full Text] [Related]  

  • 42. Red man syndrome.
    Polk RE
    Ann Pharmacother; 1998; 32(7-8):840. PubMed ID: 9681102
    [No Abstract]   [Full Text] [Related]  

  • 43. Flagellate Pattern of Toxic Erythema of Chemotherapy Due to Doxorubicin: A Case Report.
    Vadeboncoeur S; Côté B
    J Cutan Med Surg; 2016 Sep; 20(5):481-3. PubMed ID: 27068228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neutrophilic fixed drug eruption.
    Agnew KL; Oliver GF
    Australas J Dermatol; 2001 Aug; 42(3):200-2. PubMed ID: 11488716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Febrile toxiderma in children].
    Larrègue M; Vabres P; Auriol F
    Rev Prat; 1997 Sep; 47(13):1452-7. PubMed ID: 9339026
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-pigmenting fixed drug eruption induced by sorafenib.
    Tanabe K; Amoh Y; Mii S; Eto H; Iwamura M; Katsuoka K
    Acta Derm Venereol; 2010 May; 90(3):307. PubMed ID: 20526556
    [No Abstract]   [Full Text] [Related]  

  • 47. Erythematous, hemorrhagic, and necrotic plaques in an elderly man. Coumarin-induced skin necrosis.
    Sharafuddin MJ; Sanaknaki BA; Kibbi AG
    Arch Dermatol; 1992 Jan; 128(1):105, 108. PubMed ID: 1531403
    [No Abstract]   [Full Text] [Related]  

  • 48. Teicoplanin-induced skin eruption.
    Unal S; Ikizoglu G; Demirkan F; Kaya TI
    Int J Dermatol; 2002 Dec; 41(12):948-9. PubMed ID: 12492999
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug-induced skin diseases.
    Hardie RA; Savin JA
    Br Med J; 1979 Apr; 1(6168):935-7. PubMed ID: 155489
    [No Abstract]   [Full Text] [Related]  

  • 50. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome.
    Rapaport MJ; Lebwohl M
    Clin Dermatol; 2003; 21(3):201-14. PubMed ID: 12781438
    [No Abstract]   [Full Text] [Related]  

  • 51. Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
    Abadías-Granado I; Palma-Ruiz AM; Cerro PA; Morales-Callaghan AM; Gómez-Mateo MC; Gilaberte Y; Schwartz RA
    J Eur Acad Dermatol Venereol; 2021 Jan; 35(1):e5-e7. PubMed ID: 32870539
    [No Abstract]   [Full Text] [Related]  

  • 52. Ichthyosiform eruption and facial erythema secondary to ponatinib therapy.
    Munera-Campos M; Carrascosa JM; Quer A; Ferrándiz C
    J Dtsch Dermatol Ges; 2020 Jul; 18(7):743-747. PubMed ID: 32589336
    [No Abstract]   [Full Text] [Related]  

  • 53. [Drug eruption of erythema multiforme caused by amikacin in a case].
    Liu QY; Wang LF
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):187. PubMed ID: 15833189
    [No Abstract]   [Full Text] [Related]  

  • 54. Adverse cutaneous reactions to medications.
    Kroshinsky D
    Clin Dermatol; 2020; 38(6):605-606. PubMed ID: 33341194
    [No Abstract]   [Full Text] [Related]  

  • 55. Extensive fixed drug eruption secondary to vancomycin.
    Gilmore ES; Friedman JS; Morrell DS
    Pediatr Dermatol; 2004; 21(5):600-2. PubMed ID: 15461771
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute generalized exanthematous pustulosis possibly induced by acarbose.
    Wu CS; Chang WY; Lan CC; Chen GS; Chiu HH
    Int J Dermatol; 2008 Dec; 47(12):1313-5. PubMed ID: 19126027
    [No Abstract]   [Full Text] [Related]  

  • 57. Drug-associated skin lesions in a patient with myelofibrosis receiving ruxolitinib.
    Fournier JB; Cummings F; Cannella J; Breen C; Zhou L; Iwamoto S
    Dermatol Online J; 2014 Oct; 20(10):. PubMed ID: 25526003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Erythema-multiforme-like eruption from antibiotics of 3 different groups.
    Munoz D; Del Pozo MD; Audicana M; Fernandez E; Fernandez De Corres LF
    Contact Dermatitis; 1996 Mar; 34(3):227-8. PubMed ID: 8833478
    [No Abstract]   [Full Text] [Related]  

  • 59. Grade III hand-foot skin reaction induced by sorafenib.
    Chiriac A; Coros MF; Podoleanu C; Stolnicu S
    An Bras Dermatol; 2017; 92(4):590-591. PubMed ID: 28954127
    [No Abstract]   [Full Text] [Related]  

  • 60. Paclitaxel-induced neutrophilic adverse reaction and acral erythema.
    Cruz A; Temu T; Hines-Telang G; Kroumpouzos G
    Acta Derm Venereol; 2011 Jan; 91(1):86-7. PubMed ID: 21031283
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.